Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility

Experimental Eye Research

Volumn 78, Issue 3, 2004, Pages 639-651

  Kiland, J A ^a   Gabelt, B T ^a   Kaufman, P L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Aqueous humor outflow facility; Aqueous humor suppression; Ascorbate; Dorzolamide; Fibronectin; Monkey eye; Prostaglandin F2 isopropyl ester; Timolol; Trabecular meshwork

Indexed keywords

ASCORBIC ACID; DORZOLAMIDE; PROSTAGLANDIN F2 ALPHA; TIMOLOL;

ANIMAL CELL; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; AQUEOUS HUMOR FLOW; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; EPITHELIUM; GLAUCOMA; INTRAOCULAR PRESSURE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REDUCTION; TRABECULAR MESHWORK;

EID: 0842287985     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.11.001     Document Type: Article

References (53)

1. Allen-Hoffman B.L., Mosher D.F. Matrix assembly sites for exogenous fibronectin are decreased on human fibroblasts after treatment with agents which increase intracellular cAMP. J. Biol. Chem. 262:1987;14361-14365.
2. Asseff C.F., Weisman R.L., Podos S.M., Becker B. Ocular penetration of pilocarpine in primates. Am. J. Ophthalmol. 75:1973;212-215.
3. Babizhayev M.A., Brodskaya M.W. Fibronectin detection in drainage outflow system of human eyes in ageing and progression of open-angle glaucoma. Mech. Ageing Dev. 47:1989;145-157.
4. Bárány E.H. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest. Ophthalmol. 2:1964;135-143.
5. Becker B. Carbonic anhydrase and the formation of aqueous humor. Am. J. Ophthalmol. 47:1959;342-360.
6. Becker B. Vanadate and aqueous humor dynamics. Invest. Ophthalmol. Vis. Sci. 10:1980;1156-1165.
7. Becker B. Does hyposecretion of aqueous humor damage the trabecular meshwork? J. Glaucoma. 4:1995;303-305.
8. Brubaker R.F. Mechanism of action of bimatoprost (Lumigan™). Survey Ophthalmol. 45:2001;S347-S351. Suppl. 4.
9. Brubaker R.F., Maurice D.M., McLaren J.W. Fluorophotometry of the anterior segment. Masters B.R. Noninvasive Diagnostic Techniques in Ophthalmology. 1990;248-280 Springer, New York. (Chapter 15).
10. Brubaker R.F., McLaren J. Uses of fluorophotometry in glaucoma research. Ophthalmology. 92:1985;884-890.
11. Chu T.C., Candia O.A. Active transport of ascorbate across the isolated rabbit ciliary epithelium. Invest. Ophthalmol. Vis. Sci. 4:1988;594-599.
12. Coakes R.L., Brubaker R.F. The mechanism of timolol in lowering intraocular pressure. Arch. Ophthalmol. 96:1978;2045-2048.
13. 2α isopropylester on intraocular pressure, refraction, and pupil diameter in monkeys. Invest. Ophthalmol. Vis. Sci. 32:1991;510-519.
14. 2α on aqueous humor dynamics in the cynomolgus monkey. Curr. Eye Res. 6:1987;1035-1044.
15. Crook R.B., Riese K. Beta-adrenergic stimulation of Na+, K+, Cl- cotransport in fetal nonpigmented ciliary epithelial cells. Invest. Ophthalmol. Vis. Sci. 37:1996;1047-1057.
16. Erickson-Lamy K.A., Kaufman P.L., McDermott M.L., France N.K. Comparative anesthetic effects on aqueous humor dynamics in the cynomolgus monkey. Arch. Ophthalmol. 102:1984;1815-1820.
17. Fechtner R.D. Beta blockers. Ophthalmology Monographs, vol. 13. Glaucoma Medical Therapy Principles and Management. 1999;The Foundation of the American Academy of Ophthalmology, San Francisco. pp. 25-39 (Chapter 2).
18. Floyd B.B., Cleveland P.H., Worthen D.M. Fibronectin in human trabecular drainage channels. Invest. Ophthalmol. Vis. Sci. 26:1985;797-804.
19. 2α increases uveoscleral outflow in the cynomolgus monkey. Exp. Eye Res. 49:1989;389-402.
20. 2α on trabecular outflow facility in cynomolgus monkeys. Exp. Eye Res. 51:1990;87-91.
21. Harris J.E. Problems in drug penetration. Leopold I.H. Symposium on Ocular Therapy. 1968;96-105 CV Mosby, St Louis. (Chapter 3).
22. Janes R.G., Stiles J.F. The penetration of C14-labeled atropine into the eye: a comparison of methods of application. Arch. Ophthalmol. 62:1959;69-74.
23. Kaufman P.L., Davis G.E. Minified Goldmann applanating prism for tonometry in monkeys and humans. Arch. Ophthalmol. 98:1980;542-546.
24. Kerstetter J.R., Brubaker R.F., Wilson S.E., Kullerstrand L.J. Prostaglandin F2 alpha-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow. Am. J. Ophthalmol. 105:1988;30-34.
25. Kiland J.A., Peterson J.A., Gabelt B.T., Kaufman P.L. Effect of DMSO and exchange volume on outflow resistance washout and response to pilocarpine during anterior chamber perfusion in monkeys. Curr. Eye Res. 16:1997;1215-1220.
26. Kim K.S., Lee B.H., Kim J.S. The measurement of fibronectin concentrations in human aqueous humor. Korean J. Ophthalmol. 6:1992;1-5.
27. Kinsey V.E. Comparative chemistry of aqueous humor in posterior and anterior chambers of the rabbit eye. Arch. Ophthalmol. 50:1953;401-417.
28. Korenfeld M.S., Becker B. Atrial natriuretic peptides. Invest. Ophthalmol. Vis. Sci. 11:1989;2385-2392.
29. Lee P.Y., Podos S.M., Severin C. Effect of prostaglandin F2 alpha on aqueous humor dynamics of rabbit, cat, and monkey. Invest. Ophthalmol. Vis. Sci. 25:1984;1087-1093.
30. Linnér E. A method for determining the rate of plasma flow through the secretory part of the ciliary body. Acta Phys. Scand. 22:1950;83-86.
31. Lippa E., et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch. Ophthalmol. 110:1992;495-499.
32. Lütjen-Drecoll E., Futa R., Rohen J. Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 21:1981;563-573.
33. Lütjen-Drecoll E., Kaufman P.L. Long-term timolol and epinephrine in monkeys. II. Morphological alterations in trabecular meshwork and ciliary muscle. Trans. Ophthalmol. Soc. UK. 105:1986;196-207.
34. Lütjen-Drecoll E., Shimizu T., Rohrbach M., Rohen J.W. Quantitative analysis of plaque material in the inner- and outer wall of Schlemm's canal in normal and glaucomatous eyes. Exp. Eye Res. 42:1986;443-455.
35. Maren T.H., Godman D.R., Pancorbo B.M., Vogh B.P. Timolol decreases aqueous humor flow, but not Na+ movement from plasma to aqueous. Invest. Ophthalmol. Vis. Sci. 11:1997;2385-2392.
36. Maus T.L., Larsson L.I., McLaren J.W., Brubaker R.F. Comparison of dorzolamide and acetazolamide as suppressor of aqueous humor flow in humans. Arch. Ophthalmol. 115:1997;45-49.
37. Millar C., Kaufman P.L. Aqueous humor: secretion and dynamics. Tasman W. Duane's Foundations of Clinical Ophthalmology. vol. 2:1995;1-51 Lippincott-Raven, Philadelphia. (Chapter 6).
38. Millar J.C., Wilson W.S. Drug effects of intraocular pressure and vascular flow in the bovine perfused eye using radiolabelled microspheres. J. Ocular Pharmacol. 11:1995;11-23.
39. 2αisopropylester in the cynomolgus monkey. Exp. Eye Res. 48:1989;707-716.
40. Robinson J.C., Kaufman P.L. Effects and interactions of epinephrine, norepinephrine, timolol, and betaxolol on outflow facility in the cynomolgus monkey. Am. J. Ophthalmol. 109:1990;189-194.
41. Robinson J., Kaufman P. Dose-dependent suppression of aqueous humor formation by timolol in the cynomolgus monkey. J. Glaucoma. 2:1993;251-256.
42. Rodrigues M.M., Katz S.I., Foidar J.M., Spaeth G.L. Collagen, factor VIII antigen, and immunoglobulins in the human aqueous drainage channels. Ophthalmology. 87:1980;337-345.
43. Rohen J.W. Why is intraocular pressure elevated in chronic simple glaucoma? Anatomical considerations. Ophthalmology. 90:1983;758-765.
44. Serle J.B., Podos S.M., Kitazawa Y., Wang R.F. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn. J. Ophthalmol. 42:1998;95-100.
45. Strahlman E., Tipping R., Vogel R. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group. Arch. Ophthalmol. 113:1995;1009-1016.
46. Theime H., Nass J.U., Nuskovski M., Wiederholt M. The effects of the carbonic anhydrase inhibitors methazolamide, diclofenamide, and dorzolamide on trabecular meshwork and ciliary muscle contractility. Exp. Eye Res. 69:1999;455-458.
47. Topper J.E., McLaren J., Brubaker R.F. Measurement of aqueous humor flow with scanning ocular fluorophotometers. Curr. Eye Res. 3:1984;1391-1395.
48. Umihara J., Nagata S., Nohara M., Hanai T., Usuda N., Segawa K. Localization of elastin in the normal and glaucomatous human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 35:1994;486-494.
49. Van Buskirk E.M., Bacon D.R., Fahrenbach W.H. Ciliary vasoconsriction after topical adrenergic drugs. Am. J. Ophthalmol. 109:1990;511-517.
50. Vanlandingham B.D., Brubaker R.F. Combined effect of dorzolamide and latanoprost on the rate of aqueous humor flow. Am. J. Ophthalmol. 126:1998;191-196.
51. Wang R.F., Serle J.B., Podos S.M., Sugrue M.F. MK-507 (L-671, 152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Arch. Ophthalmol. 109:1991;1297-1299.
52. Yablonski M.E., Simmerman T.J., Waltman S.R., Becker B. A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp. Eye Res. 27:1978;135-142.
53. Ziai N., Dolan J.W., Kacere R.D., Brubaker R.F. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes. Arch. Ophthalmol. 111:1993;1351-1358.